"The Genesis Heart Institute is the lead center of the Genesis Health Systems heart care services."

During the past decade, Genesis Heart Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Genesis Heart Institute" are "Coronary Artery Disease" (1 trials) and "Heart Diseases" (1 trials). Many other conditions were trialed in "Genesis Heart Institute" in a lesser frequency.

Most popular intervention types in "Genesis Heart Institute" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CGT003 (E2F Duplex Decoy)" (1 trials) and "Rate adaptive pacemaker" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Heart Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Genesis Heart Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Genesis Heart Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".